Who are we?
Naomi Shaco-Ezra is the founder and director of NSE. Naomi Shaco-Ezra obtained a Bachelor of Science (BSc) with distinction in Pharmacy and a master’s degree (MSc) with distinction in Pharmacy from the School of Pharmacy, faculty of Medicine at the Hebrew University of Jerusalem.
Among her duties:
Appointed pharmacist in leader import companies for medicines and medical equipment and in industrial companies, Chief pharmacist in pharmaceutical warehouses and in a medicines manufacturing company, pharmaceutical factory, Responsible pharmacist (QP) in import companies of medicines.
Naomi Shaco-Ezra is also the CEO of Enzymed, Regulatory Breakthroughs, enterprise for advanced regulatory solutions in the healthcare industry.
The employees of NSE are pharmacists with Israeli pharmacy license.
Hence, we can provide our clients a full pharmaceutical service and quick solutions when necessary.
Drugs Disributed by Naomi Shaco- Ezra Ltd
Opiod Dependency. Buprenorphine 8.64 mg, Naloxone HCl 2.44 mg. S.L. TAB. 7, 28.
The recommend. start. dose in adult.,
adolesc. over 15 yrs.: 1-2 tabs. of 2
mg/0.5 mg. An addit. 1-2 tabs. 2 mg/0.5
mg may be administ. on day one
depend. on the individ. pts. requirem.
Dose titrat. in steps of 2-8 mg is guided
by reassess. of the clinic. & psycholog.
status of the pt., and should not exceed
a max. single dly. dose of 24 mg.
Substit. tmt. for opioid drug dependence,
within a framework of med., social and
psycholog. tmt. in adult., adolesc. over 15
yrs. who have agreed to be treated for
addiction.
C/I: Hypersens., severe resp. insuffic.,
severe hepat. impair, acute alcoholism or
delirium tremens.
Partial Opioid Agonist/Antagonist. Buprenorphine (as HCl) 2 mg, 8 mg. TABS: 7 x 2 mg, 8 mg. See lit.
Substitut. tmt. opioid depend. within
framework of medical, social and
psycholog. tmt.
C/I: Hypersens., severe respir. insuffic.,
severe hepat. insuffic., acute alcoholism.,
delirium tremens, under 16 yrs., lact.
